You are in : Home » Results & submissions » Select UOA » 1 - Clinical Medicine » View submission: Institute of Cancer Research » Outputs » Detail

Output details

1 - Clinical Medicine

Institute of Cancer Research

Return to search Previous output Next output

Output 0 of 0 in the submission

Article title

Optimization of imidazo[4,5-b]pyridine-based kinase inhibitors: identification of a dual FLT3/Aurora kinase inhibitor as an orally bioavailable preclinical development candidate for the treatment of acute myeloid leukemia.

Type

D - Journal article

DOI

10.1021/jm300952s

Title of journal

J Med Chem

Article number

Volume number

Issue number

First page of article

8721

ISSN of journal

1520-4804

Year of publication

2012

URL

http://www.ncbi.nlm.nih.gov/pubmed/23043539

Number of additional authors

Additional information

Interdisciplinary

Cross-referral requested

Research group

None

Citation count

Proposed double-weighted

Double-weighted statement

Reserve for a double-weighted output

Non-English

English abstract